Bioresorbable Implants Market to Double, Hitting US$ 14.34 Billion by 2033 as Orthopedics and Cardiovascular Applications Redefine Surgical Outcomes | by DataM Intelligence

Download Exclusive Sample Report: https://www.datamintelligence.com/download-sample/bioresorbable-implants-market Download Exclusive Sample Report:https://www.datamintelligence.com/download-sample/bioresorbable-implants-market Browse in-depth TOC on "Bioresorbable Implants Market"  45 – Tables 46 – Figures 180 – Pages Market Segmentation – Growth Anchors By Material Type In 2024,polymer-based implants dominated with 60% of total revenues ( US$ 4.2 billion )...

Download Exclusive Sample Report: https://www.datamintelligence.com/download-sample/bioresorbable-implants-market

Browse in-depth TOC on "Bioresorbable Implants Market" 

45 – Tables
46 – Figures
180 – Pages

Market Segmentation – Growth Anchors

By Material Type

In 2024, polymer-based implants dominated with 60% of total revenues (US$ 4.2 billion). Among them, PLLA (Poly L-lactide) accounted for the largest share, widely used in orthopedic fixation. PLGA and PGA implants are gaining traction in cardiovascular applications where controlled degradation is critical. Metallic bioresorbables, although smaller (US$ 1.5 billion in 2024), are emerging fast with magnesium-based implants showing strong clinical promise.

By Application

Orthopedics generated US$ 3.8 billion in 2024, fueled by sports injury treatments, trauma fixation, and pediatric orthopedics. Bioresorbable screws, pins, and plates are becoming the standard in ACL reconstruction and fracture repair.

Cardiovascular applications contributed US$ 2.5 billion, led by bioresorbable stents. With rising cases of coronary artery disease, these stents are gaining market traction due to lower risk of late thrombosis.

By End-User

Hospitals accounted for over 65% of revenues in 2024 (US$ 4.6 billion), reflecting their central role in advanced surgical procedures. Ambulatory Surgical Centers (ASCs), valued at US$ 1.8 billion, are growing rapidly as minimally invasive surgeries shift toward outpatient settings.

Regional Insights: USA & Japan

United States

The U.S., valued at US$ 2.8 billion in 2024, leads the market due to:

Japan

Japan's market, valued at US$ 0.6 billion in 2024, is expanding rapidly. Growth is supported by:

Request for Customized Sample Report as per Your Business Requirement: https://www.datamintelligence.com/customize/bioresorbable-implants-market 

Industry Trends & 2025 Developments

Competitive Landscape: Leaders Driving the Future

Stryker Corporation

Stryker remains at the forefront with US$ 1.3 billion revenues in bioresorbable implants in 2024. Its innovations in trauma fixation and sports medicine products continue to dominate the orthopedic landscape.

Johnson & Johnson (DePuy Synthes)

Johnson & Johnson generated US$ 1.1 billion in 2024, expanding aggressively into cardiovascular and orthopedic implants. The 2025 launch of advanced PLLA-based fixation systems reinforced its strong U.S. market presence.

Bioretec Ltd

Bioretec is a rising leader with pioneering magnesium-based implants. In 2025, it secured FDA clearance for its RemeOs™ trauma fixation system, marking a milestone in metallic bioresorbables.

Zimmer Biomet & Smith+Nephew

Both companies are scaling polymer implant portfolios with a focus on sports injuries and pediatric applications. Combined, they generated US$ 1.6 billion in 2024.

Evonik Industries AG

Evonik plays a key role as a material innovator, supplying polymers (Resomer® range) that power multiple bioresorbable implant lines across the industry.

Buy This Exclusive Report at Just USD 4350 Only: https://www.datamintelligence.com/buy-now-page?report=bioresorbable-implants-market 

Strategic Outlook

The Bioresorbable Implants Market is entering its most transformative phase. Four key forces will define its trajectory:

Conclusion

The Bioresorbable Implants Market, projected to rise from US$ 7.00 billion in 2024 to US$ 14.34 billion by 2033, is no longer a niche-it is the future of surgical implants. With the U.S. leading clinical adoption and Japan setting benchmarks in innovation, the sector offers compelling opportunities for hospitals, device manufacturers, and investors.

Related Report:

About DataM Intelligence

DataM Intelligence is a renowned provider of market research, delivering deep insights through pricing analysis, market share breakdowns, and competitive intelligence. The company specializes in strategic reports that guide businesses in high-growth sectors such as nutraceuticals and AI-driven health innovations.

To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter, LinkedIn and Facebook.

Contact:
Sai Kiran
DataM Intelligence 4market Research LLP
Ground floor, DSL Abacus IT Park, Industrial Development Area
Uppal, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: [email protected]
Visit Our Website: https://www.datamintelligence.com/

Logo: https://mma.prnewswire.com/media/1858619/3573087/DataM_Intelligence_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/bioresorbable-implants-market-to-double-hitting-us-14-34-billion-by-2033-as-orthopedics-and-cardiovascular-applications-redefine-surgical-outcomes--by-datam-intelligence-302572336.html